Mesoblast Ltd operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mesoblast Ltd with three other
companies in this sector in Australia:
Clinuvel Pharmaceuticals Limited
sales of 25.75 million Australian Dollars [US$18.55 million]
of which 100%
Xrf Scientific Ltd
(24.25 million Australian Dollars [US$17.47 million]
of which 42%
was Precious Metals), and
Idt Australia Limited.
(13.30 million Australian Dollars [US$9.58 million]
Sales increased substantially in 2018:
During the year ended June of 2018, sales at
Mesoblast Ltd were A$22.42 million (US$16.15 million).
increase of 600.9%
versus 2017, when the company's sales were A$3.20 million.
Despite this increase, sales are still
below the level achieved in 2016, when Mesoblast Ltd
reported sales of A$58.52 million.